Clarification of organ specific transport mechanism of druge and its application to regulation of pharmacokinetics and pharmacodynamics

阐明药物的器官特异性转运机制及其在药代动力学和药效学调控中的应用

基本信息

  • 批准号:
    07307035
  • 负责人:
  • 金额:
    $ 3.07万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

The purpose of this research project is to clarify the organ specific transports of drugs from the view points of organ, cell, molecular and gene levels and to develop novel method for regulation of pharmacokinetics and pharmacodynamics of drugs. The following results were obtained by two years term of this research project consisted of 14 investigators :1.Several evidences were obtained for molecular and biological characteristics of transporters involved in the buccal and intestinal absorption and secretion, renal secretion and reabsorption, hepatic uptake and biliary secretion and in the brain influx and efflux transports. Cloning of transporters of PepT1, PepT2, MCT1, cMOAT,OAT-K1 and OCT2, their transport functions and tissue distribution were clarified. It was also clarified that P-glycoprotein functions as the transport barrier for lipophilic xenobiotics in the intestine and at the blood-brain barrier (BBB). Peptides were confirmed to be taken up by adsorptive-mediated endocytos … More is at the BBB to be delivered into the brain. 2.Improvement of absorption for drugs was achieved by glycosylation, endocytosis across Peyer's patches, iontophoretic method and by absorption enhancers to open tight junction. 3.Uptake of fractionated heparin by hepatocytes and Kupffer cells was clarified to be regulated by the scavenger receptor-mediated and plasma proteins-mediated mechanisms. Liver-specific delivery of drugs, proteins and gene was achieved by using galactosylated technology. Reactive oxygen species, such as superoxide and nitric oxide (NO), were clarified to play critical roles in the pathogenesis of various diseases. To overcome the oxidative stress, synthesized site-directed SOD derivatives were succeeded to deliver the targeting cells. An attractive approach for the antibody-based therapy of solid tumors was proposed and evaluated successfully by use of "vascular targeting" antibody to recognize tumor endothelial cells. 4.Using alpha 1-adrenoreceptor as a model, cloning of the receptors and detection of the tissue localization of the receptor protein were succeeded. It was indicated that uridine receptor plays some role not only in brain but also in peripheral tissues. Pharmacokinetic and pharmacodynamic behaviors for the transport in the brain, receptor binding and analgesic action were analyzed after peptazocine administration in rats. Less
本研究的目的是从器官、细胞、分子和基因水平阐明药物的器官特异性转运,为药物的药代动力学和药效学调控提供新的方法。本研究由14名研究人员组成,历时两年,取得了如下结果:1.对转运蛋白在口腔和肠道的吸收和分泌、肾脏的分泌和重吸收、肝脏的摄取和胆汁的分泌以及脑的流入和外流转运中的分子和生物学特性进行了研究。阐明了PepT1、PepT2、MCT1、cMOAT、OAT-K1和OCT2转运蛋白的克隆、转运功能和组织分布。还阐明了P-糖蛋白在肠道和血脑屏障(BBB)中作为亲脂性外源生物的转运屏障的作用。多肽被吸附介导的内吞…所摄取更多的是在BBB被传递到大脑中。2.通过糖基化、跨Peyer‘s斑片的内吞作用、离子电泳法和通过吸收促进剂打开紧密连接来改善药物的吸收。3.肝细胞和枯否细胞对分级肝素的摄取受清道夫受体和血浆蛋白两种机制的调节。利用半乳糖化技术实现了药物、蛋白质和基因的肝脏特异性递送。超氧化物歧化酶和一氧化氮(NO)等活性氧物种在各种疾病的发病机制中起着关键作用。为了克服氧化应激,合成的定点定向的SOD衍生物被成功地输送到靶向细胞。利用“血管靶向”抗体识别肿瘤内皮细胞,为实体瘤的抗体治疗提供了一种有吸引力的方法,并获得成功评价。4.以α1-肾上腺素受体为模型,成功地克隆了受体,并检测了受体蛋白的组织定位。提示尿苷受体不仅在脑内发挥一定的作用,在外周组织中也有一定的作用。分析了大鼠给药后药物在脑内转运、受体结合和镇痛作用的药代动力学和药效学行为。较少

项目成果

期刊论文数量(328)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T. Kimura: "プロドラッグによるAzidothymidineの脳移行性改善" DDS. 10 (6). 413-417 (1995)
T. Kimura:“前药改善叠氮胸苷脑分布”DDS 10 (6) (1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M. Hashida: "Hepatic targeting of drugs and proteins by chemical modification" J. Control. Release. 36 (1-2). 99-107 (1995)
M. Hashida:“通过化学修饰实现药物和蛋白质的肝脏靶向”J. Control。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M. Motoya: "糖鎖認識機構を利用した細胞特異的薬物ターゲティング(Cell-specific targeting of drugs utilizing sugar-recognition systems)" Pharm. Tech. Japan. 11 (4). 395-403 (1995)
M. Motoya:“利用糖识别系统的细胞特异性靶向”,Pharm. 11 (4) (1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Kimura: "Localization of uridine receptor on synaptic membranes" Sleep Res.24A. 128 (1995)
T. Kimura:“突触膜上尿苷受体的定位”Sleep Res.24A。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y. Nishimura: "Inhibition of puromycin-induced renal injury by a superoxide dismutase with prolonged half-life in the circulation" Nephron. 70. 460-465 (1995)
Y. Nishimura:“通过超氧化物歧化酶抑制嘌呤霉素诱导的肾损伤,并延长循环中的半衰期”肾单位。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUJI Akira其他文献

TSUJI Akira的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUJI Akira', 18)}}的其他基金

The Application of 'Passport' and 'Gateway' Proteins to the Absorption, Distribution, Excretion and Delivery of Drugs
“护照”和“门户”蛋白在药物吸收、分布、排泄和递送中的应用
  • 批准号:
    16390039
  • 财政年份:
    2004
  • 资助金额:
    $ 3.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Drug Delivery based on Multiplicity of Various Membrane Transporters
基于多种膜转运蛋白的药物递送
  • 批准号:
    12307057
  • 财政年份:
    2000
  • 资助金额:
    $ 3.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Delivery of peptide-mimetic drugs to tumors utilizing oligopeptide transporters
利用寡肽转运蛋白将肽模拟药物递送至肿瘤
  • 批准号:
    12557204
  • 财政年份:
    2000
  • 资助金额:
    $ 3.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Drug deliver by utilization of tissue specific transportes.
通过利用组织特异性运输来递送药物。
  • 批准号:
    10470510
  • 财政年份:
    1998
  • 资助金额:
    $ 3.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Intestinal absorption of drugs mediated by transporters in intestinal epithelial cells
肠上皮细胞转运蛋白介导的药物肠道吸收
  • 批准号:
    10557214
  • 财政年份:
    1998
  • 资助金额:
    $ 3.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Blood-brain barrier functioning as dynamic interface and drug delivery to the brain
血脑屏障充当动态界面和向大脑输送药物
  • 批准号:
    07457527
  • 财政年份:
    1995
  • 资助金额:
    $ 3.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clarification of transcellular transport mechanism of drugs utilizing tissue cultured cell systems
利用组织培养细胞系统阐明药物的跨细胞转运机制
  • 批准号:
    04452305
  • 财政年份:
    1992
  • 资助金额:
    $ 3.07万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Quantitative analysis of factors determining age-related change in tissue distribution of animicrobial agents
确定抗菌剂组织分布随年龄变化的因素的定量分析
  • 批准号:
    61571094
  • 财政年份:
    1986
  • 资助金额:
    $ 3.07万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

小立碗藓转录因子PpTF66调控离子通道PpSOT1在盐胁迫应答中的作用机制
  • 批准号:
    31970658
  • 批准年份:
    2019
  • 资助金额:
    52.0 万元
  • 项目类别:
    面上项目
肺炎支原体外排泵ABC Transporter在大环内酯类耐药中的作用机制研究
  • 批准号:
    81672062
  • 批准年份:
    2016
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目
PICK1对心脏局部交感神经递质的平衡调控机制研究
  • 批准号:
    31000472
  • 批准年份:
    2010
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
低氧诱导因子(HIF)以及氧化还原系统(redox)与肿瘤多药耐药(MDR)的相互作用
  • 批准号:
    31070750
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目
一个可能与水稻花粉发育相关的ABC transporter 基因的功能验证与分析
  • 批准号:
    30970274
  • 批准年份:
    2009
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
  • 批准号:
    10590033
  • 财政年份:
    2024
  • 资助金额:
    $ 3.07万
  • 项目类别:
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
减少年轻成年睾丸癌幸存者不良后果的生物行为干预
  • 批准号:
    10736501
  • 财政年份:
    2023
  • 资助金额:
    $ 3.07万
  • 项目类别:
Nicotine promotes perineural brain metastasis by activating GABAergic neurons
尼古丁通过激活 GABA 能神经元促进神经周围脑转移
  • 批准号:
    10572577
  • 财政年份:
    2023
  • 资助金额:
    $ 3.07万
  • 项目类别:
Neural Inflammation and Exercise Pressor Reflex in Heart Failure
心力衰竭中的神经炎症和运动升压反射
  • 批准号:
    10712202
  • 财政年份:
    2023
  • 资助金额:
    $ 3.07万
  • 项目类别:
Imaging Biomarkers of Neurotoxicity in Welders
焊工神经毒性的成像生物标志物
  • 批准号:
    10659057
  • 财政年份:
    2023
  • 资助金额:
    $ 3.07万
  • 项目类别:
Illumination of TAAR2 Location, Function and Regulators
TAAR2 位置、功能和调节器的阐明
  • 批准号:
    10666759
  • 财政年份:
    2023
  • 资助金额:
    $ 3.07万
  • 项目类别:
Brain Development after Early-Life Antipsychotic Treatment
早期抗精神病治疗后的大脑发育
  • 批准号:
    10629613
  • 财政年份:
    2023
  • 资助金额:
    $ 3.07万
  • 项目类别:
Functional plasticity in retinal degenerative disease
视网膜退行性疾病的功能可塑性
  • 批准号:
    10637293
  • 财政年份:
    2023
  • 资助金额:
    $ 3.07万
  • 项目类别:
Presynaptic Modulation of Synaptic Inhibition onto Hippocampal Pyramidal Neurons
海马锥体神经元突触抑制的突触前调节
  • 批准号:
    10863330
  • 财政年份:
    2023
  • 资助金额:
    $ 3.07万
  • 项目类别:
Alpha-Synuclein-Specific T cells in Parkinson's Disease Pathogenesis
帕金森病发病机制中的α-突触核蛋白特异性 T 细胞
  • 批准号:
    10752172
  • 财政年份:
    2023
  • 资助金额:
    $ 3.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了